U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CEMIPLIMAB
6QVL057INT
US Approved Rx (2018)
First approved in 2018
General
Names
9
Classification
2
Identifiers
14
Subunits
4
Related Substances
1
CEMIPLIMAB
6QVL057INT
US Approved Rx (2018)
First approved in 2018
General
Approval Year
2018
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CEMIPLIMAB
Official Name
English
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Common Name
English
CEMIPLIMAB [USAN]
Common Name
English
Cemiplimab [WHO-DD]
Common Name
English
cemiplimab [INN]
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-PD1 Monoclonal Antibody
NCI_THESAURUS
C128037
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
14
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
LACTMED
Cemiplimab
PRIMARY
CAS
1801342-60-8
PRIMARY
DAILYMED
6QVL057INT
PRIMARY
USAN
DE-88
PRIMARY
RXCUI
2058825
ALTERNATIVE
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
6QVL057INT
CEMIPLIMAB
